Showing 1281-1290 of 10735 results for "".
- Skin Cancer Champions to Host Inaugural Patient Advocacy Summithttps://practicaldermatology.com/news/skin-cancer-champions-to-host-inaugural-patient-advocacy-summit/2488209/Skin Cancer Champions will convene its inaugural Patient Advocacy Summit on October 30, 2026, in Boston, Massachusetts, bringing patients and caregivers together with clinicians and industry representatives to discuss nonmelanoma skin cancer care, emerging therapies, and patient advocacy.
- Global Study Maps Wide Disparities in Access to Dermatologic Carehttps://practicaldermatology.com/news/global-study-maps-wide-disparities-in-access-to-dermatologic-care/2488213/A global analysis of dermatologic care found substantial disparities in dermatologist availability, training opportunities, and access to specialty services, with lower-resource countries facing the greatest gaps. The cross-sectional study surveyed dermatology leaders across World Health O
- Hidradenitis Suppurativa Linked to Higher Cardiovascular Risk: Meta-Analysishttps://practicaldermatology.com/news/hidradenitis-suppurativa-linked-to-higher-cardiovascular-risk-meta-analysis/2488190/Hidradenitis suppurativa (HS) was associated with increased risk of multiple cardiovascular outcomes in a systematic review and meta-analysis encompassing 373,689 individuals with the chronic inflammatory skin disease. Cardiovascular Comorbidities and Hidradenitis Suppurativa
- Picosecond Laser Study Links Immediate Whitening to Skin Tissue Responsehttps://practicaldermatology.com/news/picosecond-laser-study-links-immediate-whitening-to-skin-tissue-response/2488179/A new in vivo study offers a closer look at what immediate whitening (IW) may represent at the tissue level following picosecond laser irradiation. Researchers publishing in Lasers in Surgery and Medicine, the study evaluated the relationship among IW, vacuole formation, and melan
- Cherry Angiomas Linked to NF1-Related Vascular Changes: Studyhttps://practicaldermatology.com/news/cherry-angiomas-linked-to-nf1-related-vascular-changes-study/2488158/Cherry angiomas may be a previously underrecognized vascular manifestation of neurofibromatosis type 1 (NF1), according to findings from a prospective comparative study in JAMA Dermatology. Investigators evaluated 259 participants (102 individuals with confirmed NF1 and 157 contro
- Phase 3 Study Shows Sustained Psoriasis Responses With SSGJ-608https://practicaldermatology.com/news/phase-3-study-shows-sustained-psoriasis-responses-with-ssgj-608/2488143/A phase 3 trial of the investigational interleukin (IL)-17A–targeting monoclonal antibody (SSGJ-608) showed high response rates through 52 weeks among adults with moderate-to-severe plaque psoriasis. Investigators for the double-blind, placebo-controlled trial included 458 adults in the sa
- AbbVie Names 34 Immunology Scholarship Recipients for 2026https://practicaldermatology.com/news/abbvie-names-34-immunology-scholarship-recipients-for-2026/2488127/AbbVie has announced 34 recipients of its 2026 AbbVie Immunology Scholarship, according to a news release, marking the 10th year of a program designed to support students living with chronic inflammatory diseases as they pursue higher education. Since the scholarship launched in 2016, AbbV
- Monophasic HA Shows Longer-Term Benefit in Nasolabial Fold Correctionhttps://practicaldermatology.com/news/monophasic-ha-shows-longer-term-benefit-in-nasolabial-fold-correction/2488118/A randomized study comparing 2 types of hyaluronic acid (HA) dermal fillers found similar early improvements in moderate-to-severe nasolabial folds (NLFs), with outcomes favoring monophasic HA at 36 weeks. Galinde et al conducted a randomized, controlled, double-blinded, intraindividual st
- Three-Part Acne Scar Protocol Shows Progressive Changes Through 139 Dayshttps://practicaldermatology.com/news/three-part-acne-scar-protocol-shows-progressive-changes-through-139-days/2488104/A multimodal protocol combining subcision, injectable treatment, and fractional laser therapy was associated with reductions in facial atrophic acne scar dimensions in a prospective case series published in Biomedicines. Ultrasound Tracks Changes Through 139 Days The stud
- D-2570 Shows High PASI Response Rates in Phase 2 Psoriasis Studyhttps://practicaldermatology.com/news/d-2570-shows-high-pasi-response-rates-in-phase-2-psoriasis-study/2488078/A novel oral TYK2 inhibitor produced significantly higher skin clearance rates than placebo in patients with moderate-to-severe plaque psoriasis, according to research published in Journal of the American Academy of Dermatology. D-2570 is a TYK2 inhibitor under development for aut